practic
evid
suggest
possibl
benefici
effect
combin
use
prebiot
probiot
improv
product
paramet
object
studi
investig
addit
saccharomyc
cerevisia
sc
prebiot
combin
lactobacillu
spp
l
bacillu
spp
b
probiot
product
paramet
econom
feasibl
four
hundr
male
pig
hybrid
commerci
genet
line
pietrain
use
control
group
kgtonn
sc
kgtonn
feed
l
b
kgtonn
sc
kgtonn
l
b
product
paramet
record
treatment
group
four
period
viscera
five
pig
per
treatment
collect
slaughter
evalu
histolog
chang
cytokin
concentr
ileum
weight
gain
group
day
group
show
statist
increas
p
feed
intak
signific
differ
p
versu
feedconvers
ratio
improv
period
group
p
eosinophil
mononuclear
infiltr
cytokin
tumor
necrosi
factora
mucosa
lower
treatment
probiot
conclus
econom
benefit
use
prebiot
probiot
diet
pig
wean
finish
pig
breed
promot
intens
commerci
industri
econom
loss
due
diseas
compromis
wellb
anim
fatten
process
limit
product
high
risk
neonat
diseas
prevent
prophylact
measur
diarrhea
pneumonia
critic
day
wean
diarrhea
caus
colibacillosi
common
zamora
reinhardt
polett
macia
extrins
caus
sudden
depriv
matern
antibodi
due
diet
chang
well
variat
temperatur
humid
environment
condit
affect
immun
system
anim
bojkovski
vasiljevi
c
stojanovi
c
rogo
zarski
fatten
phase
wean
swine
dysenteri
anoth
problem
use
antibiot
common
practic
avoid
issu
antibiot
success
use
control
diseas
spread
improv
growth
howev
use
alreadi
prohibit
countri
research
direct
toward
studi
growth
promot
affect
human
health
alvarezord
mart
arguello
carvaj
rubio
use
prebiot
probiot
pig
still
explor
improv
product
paramet
czech
mokrzycka
grela
pejzak
inform
avail
depend
type
dose
time
administr
particular
prebiot
act
stimul
sever
microorgan
benefici
gastrointestin
tract
exampl
addit
saccharomyc
cerevisia
ferment
product
shown
improv
presenc
bacteroid
lactobacillu
price
et
al
increas
villu
height
small
intestin
develop
system
immun
earlywean
piglet
specif
saccharomyc
cerevisia
cncm
abl
inhibit
enterotoxigen
escherichia
coli
induc
proinflammatori
cytokin
chemokin
associ
inhibit
mitogenactiv
protein
kinas
pathway
zongyong
et
al
case
probiot
benefit
growth
weight
gain
improv
feed
convers
musa
wu
zhu
seri
zhu
carcass
output
qualiti
jukna
jukna
simku
report
physiolog
action
probiot
depend
mainli
establish
benefici
intestin
flora
tool
cooney
decreas
competit
abil
pathogen
bacteria
robleshuayn
et
al
probiot
bacteria
viabl
microorgan
wet
frozen
lyophil
prepar
ferment
product
gagg
mattarelli
biavati
utiyama
oet
giani
ruiz
miada
research
publish
probiot
prebiot
carri
newborn
purpos
decreas
mortal
caus
diarrhea
therapeut
dose
vari
wide
viabl
organ
per
anim
per
day
number
organ
must
enough
trigger
benefici
respons
host
without
induc
digest
disord
santo
et
al
inform
combin
prebiot
probiot
pig
wean
scarc
purpos
present
research
evalu
one
prebiot
two
probiot
combin
assess
product
paramet
intestin
morpholog
respons
econom
feasibl
pig
wean
day
age
studi
conduct
santa
rosa
pig
farm
physiolog
patholog
anim
nutrit
laboratori
school
veterinari
medicin
benem
erita
universidad
aut
onoma
de
puebla
buap
site
locat
valley
tecamachalco
puebla
mexico
latitud
north
longitud
west
masl
domin
mild
climat
mean
temperatur
rainfal
mm
per
year
instituto
nacion
de
estad
geograf
e
inform
atica
inegi
total
male
pig
hybrid
commerci
genet
line
lm
pietrain
use
select
anim
wean
day
old
weight
rang
kg
live
weight
anim
distribut
weight
anim
per
follow
treatment
control
group
without
dose
preprobiot
supplement
group
combin
strain
kgtonn
saccharomyc
cerevisia
diamond
v
mill
cedar
rapid
ia
usa
contain
least
yeast
cultur
total
microbi
activ
coloni
form
unit
cfu
oz
kgtonn
mixtur
prepar
equal
proport
lactobacillu
spp
contain
least
cfug
fddv
nutrish
bacillu
spp
bioplu
manufactur
chr
hansen
horsholm
denmark
combin
spraydriedsporeform
b
subtili
b
licheniformi
contain
least
viabl
sporesg
kgtonn
saccharomyc
cerevisia
kgtonn
lactobacillu
spp
bacillu
spp
treatment
repeat
five
time
pig
per
pen
provid
feeder
automat
water
care
handl
anim
approv
ethic
committe
school
veterinari
medicin
anim
scienc
buap
regul
mexican
offici
standard
anim
care
publish
sagarpa
weekli
store
plastic
contain
sampl
obtain
period
determin
dri
matter
content
use
forc
air
oven
pig
free
access
feed
consid
daili
surplu
hopper
feeder
anim
weigh
begin
studi
averag
daili
gain
adg
record
period
day
weigh
perform
hour
provid
feed
use
electron
scale
accuraci
g
torrey
exico
citi
exico
amount
feed
offer
anim
base
dri
matter
coincid
weigh
period
specifi
feed
intak
fi
feedconvers
ratio
fcr
calcul
follow
formula
fcr
fiadg
end
feed
trial
pig
weigh
final
weight
fw
slaughter
accord
mexican
offici
standard
sagarpa
use
captiv
bolt
stunner
bleed
cut
jugular
vein
slaughter
anim
eviscer
carcass
cool
chamber
maintain
follow
day
cold
carcass
weight
ccw
record
cold
dress
percentag
calcul
ccw
total
five
pig
treatment
group
randomli
select
viscera
pig
collect
immedi
slaughter
store
briefli
plastic
bag
previous
identifi
intestin
length
measur
cm
long
sampl
obtain
ileum
fix
buffer
formalin
hour
embed
paraffin
lmthick
section
cut
sampl
section
stain
hematoxylineosin
clinic
sign
digest
diseas
present
select
pig
howev
analysi
microscop
lesion
ileum
level
perform
determin
morpholog
chang
intestin
epithelium
mucosa
submucosa
descript
histolog
chang
ileum
perform
lesion
atrophi
relat
villi
crypt
assess
scale
rang
normal
grade
mild
grade
moder
grade
sever
grade
microscop
variabl
quantifi
likert
scale
photo
intestin
select
treatment
base
clariti
common
find
observ
microscopi
previous
intestin
tissu
sampl
thaw
room
temperatur
one
hundr
milligram
ileum
homogen
ml
phosphatebuff
salin
pb
solut
moll
nacl
mmoll
napo
contain
antiproteas
mmoll
phenylmethanesulfonyl
fluorid
mmoll
benzethonium
chlorid
mmoll
ethylenediaminetetraacet
acid
ki
aprotinin
tween
sampl
centrifug
min
g
supernat
use
immedi
elisa
third
dilut
pb
quantiti
interleukin
tumor
necrosi
factor
alpha
tnfa
measur
use
commerci
avail
kit
elisaquantikin
kit
r
biotechn
brand
system
inc
minneapoli
mn
usa
sampl
analyz
triplic
within
singl
assay
tnfa
sensit
pgml
respect
data
assess
normal
homogen
varianc
use
shapirowilk
test
leven
test
respect
data
analyz
univari
analysi
use
spss
version
softwar
spss
inc
chicago
il
usa
repetit
per
pen
consid
one
experiment
unit
alpha
level
use
determin
signific
differ
use
tukey
test
set
p
statist
model
use
follow
nonparametr
variabl
observ
intestin
morpholog
analyz
nonparametr
statist
analysi
use
kruskalw
test
econom
analysi
measur
nutrit
feasibl
level
invest
meat
product
process
base
detail
studi
feed
invest
prebiot
probiot
ad
diet
consid
cost
return
invest
interact
effect
treatment
found
p
probiot
combin
villi
length
lower
p
versu
ph
ileum
decreas
one
unit
treatment
group
supplement
probiot
epithelium
statu
better
eosinophil
mononuclear
infiltr
mucosa
lower
probiot
treatment
wherea
mononuclear
infiltr
submucosa
increas
drastic
compar
treatment
hyperplasia
peyer
patch
congest
submucosa
venul
show
uniform
data
differ
disproportion
figur
show
photograph
represent
histolog
section
obtain
ileum
pig
day
age
histolog
examin
ileum
show
mild
moder
lesion
four
experiment
treatment
slight
colon
bacteria
adher
enterocyt
second
patholog
find
mononuclear
eosinophil
infiltr
intestin
epithelium
also
present
four
treatment
anoth
condit
congest
found
greater
intens
ileum
mix
infiltr
found
lamina
propria
mucosa
submucosa
edema
congest
cell
necrosi
peyer
patch
diagnos
lowest
microscop
lesion
diagnos
treatment
mild
except
sever
alter
five
pig
treatment
f
g
u
r
e
microscop
lesion
ileum
ileum
moder
inflammatori
respons
predomin
macrophag
lymphocyt
eosinophil
lamina
propria
observ
indic
circl
slight
congest
mucosa
indic
arrow
prebiot
ileum
lamina
propria
ileum
show
moder
mononuclear
infiltr
indic
circl
congest
mucos
submucos
capillari
indic
arrow
probiot
ileum
mucosa
show
moder
mononuclear
infiltr
mild
eosinophil
infiltr
indic
circl
capillari
congest
indic
arrow
interact
prebiot
probiot
lymphoid
tissu
associ
intestin
peyer
patch
indic
circl
hyperplasia
germin
center
found
indic
arrow
greater
versu
follow
net
incom
versu
one
problem
attribut
earli
wean
pig
reduct
feed
intak
particular
first
week
wean
like
caus
intestin
villou
atrophi
poor
nutrient
absorpt
affect
weight
gain
utiyama
et
al
therefor
use
prebiot
oligosaccharid
incorpor
diet
dose
gkg
induc
benefici
popul
microorgan
differ
intestin
segment
maintain
health
anim
mikkelsen
jakobsen
jensen
howev
postwean
use
prebiot
probiot
question
sever
author
fedalto
tkacz
ader
mikkelsen
et
al
sanch
et
al
santo
et
al
report
lack
improv
weight
gain
feed
convers
day
age
theori
prebiot
improv
digest
volum
result
increas
microbi
biomass
consequ
action
probiot
suitabl
lan
tran
kim
utiyama
et
al
studi
adg
respons
greatest
combin
use
prebiot
probiot
fcr
improv
throughout
fatten
period
anoth
studi
report
increas
weight
gain
combin
probiot
tara
vahjen
simon
use
anaerob
ferment
product
saccharomyc
cerevisia
also
report
improv
weight
gain
wean
piglet
due
increas
benefici
microorgan
intestin
price
et
al
therefor
inconsist
among
abovement
author
explain
type
prebiot
probiot
use
experi
inclus
level
effici
prebiot
feed
improv
concentr
bifidobacteria
lactobacilli
intestin
although
high
concentr
might
affect
digest
nutrient
cross
prebiot
improv
energi
effici
allow
anim
gener
muscl
mass
desir
bodi
weight
market
branner
rothmaier
tnfa
mostli
deriv
lymphocyt
macrophag
produc
lower
concentr
preprobiot
perhap
type
cytokin
also
produc
endotheli
cell
probiot
resist
low
ph
proteolyt
enzym
digest
tract
hou
zeng
yang
liu
qiao
retent
time
mixtur
materi
ingest
gastric
juic
previous
digest
food
influenc
surviv
probiot
strain
administ
anterior
part
small
intestin
import
defens
rapid
flow
veloc
prevent
excess
growth
microb
microorgan
adher
epithelium
presenc
bile
region
also
repress
surviv
activ
microorgan
cecum
probiot
compet
nativ
microflora
alreadi
establish
healthi
anim
rate
passag
slower
microorgan
establish
easili
morai
berto
hauptli
wechsler
trindad
area
epitheli
cell
continu
releas
cover
intestin
bacteri
cell
includ
lactobacilli
chiquieri
et
al
studi
continu
administr
probiot
throughout
entir
fatten
phase
maintain
constant
prolifer
lactic
acid
bacteria
physiolog
food
particl
take
approxim
hour
pass
small
intestin
choudhari
shind
ramtek
time
difficult
pathogen
bacteria
multipli
quickli
consequ
probiot
predomin
estienn
hartsock
harper
lactic
acid
bacteria
lactobacillu
streptococcu
spp
gener
predomin
small
intestin
help
reduc
ph
stomach
product
lactic
acid
organ
acid
utiyama
et
al
immun
system
piglet
fulli
function
wean
possibl
need
stimul
prevent
diarrhea
probiot
stimul
immun
system
hypersensit
respons
earli
wean
piglet
induc
compon
diet
perform
health
assess
growth
rate
use
feed
number
death
occurr
diarrhea
rai
yadav
lakhani
benefit
report
combin
prebiot
probiot
pig
stimul
intestin
motil
miner
absorpt
elimin
ammonium
stimul
immun
system
cross
yang
et
al
studi
prebiot
influenc
major
nondigest
oligosaccharid
control
manipul
microbi
composit
andor
activ
help
maintain
benefici
microflora
turn
inhibit
growth
pathogen
combin
prebiot
probiot
improv
stabil
surviv
probiot
passag
digest
tract
zimmermann
et
al
mainli
ingest
prebiot
stimul
activ
preexist
speci
probiot
strain
lactobacilli
bacilli
bifidobacteria
compet
adhes
access
attach
site
epitheli
cell
provid
mannosespecif
interact
prevent
colo
cross
hou
et
al
demonstr
abil
probiot
improv
intestin
epitheli
barrier
function
dead
pig
choudhari
et
al
found
posit
relationship
reduc
mortal
addit
growth
promot
base
prebiot
probiot
pig
feed
invest
return
rate
irr
determin
consid
variabl
cost
attribut
treatment
benefit
deriv
sale
live
pig
highest
econom
benefit
follow
better
irr
similarli
modesto
et
al
found
piglet
fed
growth
promot
base
prebiot
probiot
better
econom
benefit
postwean
mortal
risk
decreas
due
addit
effect
prebiot
probiot
intak
better
treatment
intestin
cytokin
concentr
lower
ph
ileum
neutral
inhibit
growth
pathogen
enterobacteria
intestin
tract
econom
greater
benefit
obtain
use
kgtonn
prebiot
kgtonn
probiot
food
margin
return
found
administr
kgtonn
growth
promot
base
prebiot
kgtonn
base
probiot
diet
pig
wean
finish
recommend
addit
achiev
increas
weight
gain
improv
feed
convers
net
econom
benefit
j
efr
en
ram
http
